Bio Rad Laboratories Inc (NYSE:BIO)
| 523.09 Delayed Data As of Aug 07 |  -2.13 / -0.41%Today’s Change | 309.38 Today|||52-Week Range 540.06 | +41.36% Year-to-Date |
Latest BIO News | Press Releases
| Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript Jul 31 / MotleyFool.com - Paid Partner Content | Bio-Rad Labs Q2 2020 Earnings Preview Jul 29 / Seeking Alpha - Paid Partner Content |
| Bio-Rad Labs EPS beats by $0.46, beats on revenue Jul 30 / Seeking Alpha - Paid Partner Content | Notable earnings after Thursday's close Jul 29 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 525.22 |
| Today’s open | 522.80 |
| Day’s range | 518.51 - 527.00 |
| Volume | 181,442 |
| Average volume (3 months) | 269,859 |
| Market cap | $12.9B |
Data as of 4:00pm ET, 08/07/2020
Growth & Valuation
| Earnings growth (last year) | +380.91% |
| Earnings growth (this year) | +9.75% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +0.97% |
| P/E ratio | 8.1 |
| Price/Sales | 4.83 |
| Price/Book | 2.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | +1.66 | +0.79% |
| PKIPerkinElmer Inc | +0.27 | +0.23% |
| QGENQiagen NV | +0.43 | +0.92% |
| BRKRBruker Corp | +0.65 | +1.49% |
Data as of 4:00pm ET, 08/07/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | $1.80 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $1.8B |
| Net profit margin | 76.08% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
